Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1985
Characteristic T cell dysfunction in patients with chronic active Epstein-Barr virus infection (chronic infectious mononucleosis)G Tosato, S Straus, W Henle, et al.Proceedings of the National Academy of Sciences of the United States of America|December 15, 1991
The role of lactic acid in autocrine B-cell growth stimulationS E Pike, S P Markey, C Ijames, et al.The Journal of Investigative Dermatology|November 17, 2001
The angiogenesis inhibitor vasostatin does not impair wound healing at tumor-inhibiting dosesB Lange-Asschenfeldt, P Velasco, M Streit, et al.Blood|August 29, 2000
Effective targeting of tumor vasculature by the angiogenesis inhibitors vasostatin and interleukin-12L Yao, S E Pike, J Setsuda, et al.The Journal of Clinical Investigation|June 1, 1984
Abnormally elevated frequency of Epstein-Barr virus-infected B cells in the blood of patients with rheumatoid arthritisG Tosato, A D Steinberg, R Yarchoan, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1986
Epstein-Barr virus immortalization of normal cells of B cell lineage with nonproductive, rearranged immunoglobulin genesG Tosato, G E Marti, R Yarchoan, et al.Cancer Research|June 15, 1997
Role of the p53 tumor suppressor gene in the tumorigenicity of Burkitt's lymphoma cellsB W Cherney, K G Bhatia, C Sgadari, et al.Science (New York, N.Y.)|January 29, 1988
Monocyte-derived human B-cell growth factor identified as interferon-beta 2 (BSF-2, IL-6)G Tosato, K B Seamon, N D Goldman, et al.The Journal of Experimental Medicine|December 22, 1998
Vasostatin, a calreticulin fragment, inhibits angiogenesis and suppresses tumor growthS E Pike, L Yao, K D Jones, et al.Blood|February 1, 1994
Regression of experimental Burkitt's lymphoma induced by Epstein-Barr virus-immortalized human B cellsG Tosato, C Sgadari, K Taga, et al.Pageof 3